Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Date of this Version
The benefits with respect to mortality that had been observed among patients originally assigned to blood-pressure–lowering therapy were attenuated but still evident at the end of follow-up. There was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events.
This document has been peer reviewed.